Wolverine Trading

Wolverine Trading’s Esperion Therapeutics ESPR Stock Holding History

Wolverine Trading’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,805	Closed	-$20.9K	–	5770
2025 Q2	$10.7K	Buy	+10,805	New	+$10.8K	﹤0.01%	4494
2024 Q4	–	Sell	-10,969	Closed	-$25.6K	–	5408
2024 Q3	$18.4K	Buy	+10,969	New	+$22.1K	﹤0.01%	4644
2018 Q3	–	Sell	-26,079	Closed	-$1.89M	–	5155
2018 Q2	$1.89M	Hold	26,079	–	–	﹤0.01%	1643
2018 Q1	$1.89M	Buy	26,079 +16,878	+183%	+$1.24M	﹤0.01%	1643
2017 Q4	$606K	Buy	+9,201	New	+$495K	﹤0.01%	2776
2017 Q3	–	Sell	-11,155	Closed	-$538K	–	4567
2017 Q2	$527K	Buy	+11,155	New	+$410K	﹤0.01%	2381

Other funds holding ESPR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return